Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. - Sundstrom,S.; Bremnes,R.M.; Kaasa,S. (J Clin Oncol, 2002)